Project 4

$105,110P01FY2011NSNIH

University Of California Los Angeles, Los Angeles CA

Investigators

Linked publications & trials

Paper 33961402 Paper 33679289 Paper 30622123 Paper 30399166 Paper 30328005 Paper 27727458 Paper 26511321 Paper 26459562 Paper 25965274 Paper 25557022 Paper 25305079 Paper 25138218 Paper 25121776 Paper 25102080 Paper 24982630 Paper 24887207 Paper 24692094 Paper 24684599 Paper 24391857 Paper 24344300 Paper 24341866 Paper 24032979 Paper 23781106 Paper 23774650 Paper 23667637 Paper 23443629 Paper 23383400 Paper 23339308 Paper 23118898 Paper 22797194 Paper 22692797 Paper 22332887 Paper 22094223 Paper 21298813 Paper 21068388 Paper 20871097 Paper 20682279 Paper 20621283 Paper 20515040 Paper 20209111 Paper 20161347 Paper 20067574 Paper 19805550 Paper 19651777 Paper 19596823 Paper 19483195 Paper 19416874 Paper 19271992 Paper 19227972 Paper 19077113 Paper 19022905 Paper 18378676 Paper 18316367 Paper 18301754 Paper 18192269 Paper 17683122 Paper 17592131 Paper 17441748 Paper 17092942 Paper 16876491 Paper 16574746

Abstract

PROJECT SUMMARY (See instructions): Structural and biochemical methods will be used to characterize amyloid-Uke fibrils of SODl and its segments. The overall goals are to understand the process of fibrillation of SODl in vitro and in cells, and to determine atomic structures for the fibril-defining segments of SODl. This informatin will be used in the process of structure-based design, to create inhibitors of fibrillation of SODl and its mutants. These inhibitors can be lead compounds for drugs against SODl fibrillation and possibly fALS. A high-risk goal is to characterize the structure of SODl aggregates that form in human cells [see Project 3). In particular, micro-X-ray diffraction will be used to assess the possibility that SODl is in the amyloid state in cells.

View original record on NIH RePORTER →